KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 134 filers reported holding KARUNA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 2.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $60,136,900 | +4.7% | 190,000 | -44.1% | 0.98% | -4.9% |
Q3 2023 | $57,463,546 | -22.1% | 339,840 | -0.0% | 1.03% | -17.1% |
Q2 2023 | $73,722,061 | +19.4% | 339,968 | +0.0% | 1.25% | +10.0% |
Q1 2023 | $61,739,073 | -39.5% | 339,898 | -34.6% | 1.13% | -43.7% |
Q4 2022 | $102,121,050 | -12.6% | 519,700 | 0.0% | 2.01% | -12.4% |
Q3 2022 | $116,896,000 | +49.2% | 519,700 | -16.1% | 2.30% | +37.2% |
Q2 2022 | $78,360,000 | -17.4% | 619,400 | -17.2% | 1.68% | +12.8% |
Q1 2022 | $94,839,000 | -3.2% | 748,000 | 0.0% | 1.49% | +18.7% |
Q4 2021 | $97,988,000 | +7.1% | 748,000 | 0.0% | 1.25% | +3.7% |
Q3 2021 | $91,503,000 | +7.3% | 748,000 | 0.0% | 1.21% | +5.4% |
Q2 2021 | $85,265,000 | -27.0% | 748,000 | -23.0% | 1.14% | -33.8% |
Q1 2021 | $116,753,000 | +27.5% | 971,077 | +7.8% | 1.73% | +23.2% |
Q4 2020 | $91,540,000 | +31.4% | 901,077 | 0.0% | 1.40% | +2.9% |
Q3 2020 | $69,671,000 | -30.6% | 901,077 | 0.0% | 1.36% | -37.5% |
Q2 2020 | $100,434,000 | +54.8% | 901,077 | 0.0% | 2.18% | +3.9% |
Q1 2020 | $64,878,000 | +300.8% | 901,077 | +319.4% | 2.10% | +360.7% |
Q4 2019 | $16,186,000 | +235.0% | 214,843 | -27.4% | 0.46% | +185.0% |
Q3 2019 | $4,831,000 | -78.1% | 296,000 | -73.9% | 0.16% | -76.2% |
Q2 2019 | $22,060,000 | – | 1,136,234 | – | 0.67% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 47,376 | $8,605,377 | 3.04% |
CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |